UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Westbourne Investment Advisors Inc.

Westbourne Investment Advisors Inc. lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,296 shares of the healthcare conglomerate’s stock after selling 35 shares during the period. Westbourne Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $1,735,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the company. Keebeck Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 11.6% in the second quarter. Keebeck Wealth Management LLC now owns 10,788 shares of the healthcare conglomerate’s stock worth $5,185,000 after acquiring an additional 1,122 shares in the last quarter. Ascension Capital Advisors Inc. acquired a new position in UnitedHealth Group in the third quarter worth $216,000. Physician Wealth Advisors Inc. acquired a new stake in UnitedHealth Group during the third quarter worth about $207,000. Bartlett & Co. LLC boosted its position in UnitedHealth Group by 5.7% during the 3rd quarter. Bartlett & Co. LLC now owns 164,353 shares of the healthcare conglomerate’s stock valued at $82,865,000 after purchasing an additional 8,873 shares during the period. Finally, Great Valley Advisor Group Inc. increased its holdings in shares of UnitedHealth Group by 5.8% in the 3rd quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock worth $17,292,000 after acquiring an additional 1,884 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insiders Place Their Bets

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Down 0.1 %

Shares of NYSE UNH traded down $0.56 during midday trading on Thursday, reaching $492.54. The company’s stock had a trading volume of 1,295,798 shares, compared to its average volume of 4,055,827. The stock has a market capitalization of $454.09 billion, a price-to-earnings ratio of 20.64, a PEG ratio of 1.34 and a beta of 0.54. UnitedHealth Group Incorporated has a fifty-two week low of $445.68 and a fifty-two week high of $554.70. The stock has a 50 day simple moving average of $503.73 and a 200-day simple moving average of $518.79. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating the consensus estimate of $5.98 by $0.18. The firm had revenue of $94.43 billion during the quarter, compared to analysts’ expectations of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The business’s quarterly revenue was up 14.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $5.34 earnings per share. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.53%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 31.54%.

Analyst Ratings Changes

UNH has been the subject of a number of recent research reports. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a report on Friday, January 19th. Oppenheimer reiterated an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a research report on Wednesday, January 17th. HSBC reaffirmed a “reduce” rating and set a $480.00 price objective (down previously from $550.00) on shares of UnitedHealth Group in a report on Monday, December 18th. Barclays assumed coverage on shares of UnitedHealth Group in a research report on Wednesday, March 6th. They set an “overweight” rating and a $551.00 price target on the stock. Finally, Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $579.33.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.